Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 9/20 | 0.72 |
| ▸ | LPL | P06858 | 8/20 | 0.72 |
| ▸ | ESR1 | P03372 | 2/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.36 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.36 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.36 |
| ▸ | SNCA | P37840 | 1/20 | 0.35 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.35 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.35 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.33 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.33 |
| ▸ | CHRNG | P07510 | 1/20 | 0.33 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1935027 | 0.95 | LIPG (0.68) | LIPGLPLPRMT5WDR77SNCA | |
| SCHEMBL29980865 | 0.95 | LIPG (0.68) | LIPGLPLPRMT5WDR77SNCA | |
| SCHEMBL12246537 | 0.94 | LIPG (0.63) | LIPGLPLESR1ESR2PRMT5 | |
| SCHEMBL10457213 | 0.93 | LIPG (0.69) | LIPGLPLPRMT5WDR77SNCA | |
| SCHEMBL14506120 | 0.92 | LIPG (0.68) | LIPGLPLESR1ESR2PRMT5 | |
| SCHEMBL1007806 | 0.89 | LIPG (0.76) | LIPGLPLSNCADGAT1IRAK4 | |
| SCHEMBL13098741 | 0.89 | LIPG (0.71) | LIPGLPLSNCADGAT1IRAK4 | |
| SCHEMBL17268988 | 0.88 | LIPG (0.74) | LIPGLPLESR1ESR2PRMT5 | |
| SCHEMBL12626766 | 0.88 | LIPG (0.66) | LIPGLPLPRMT5WDR77DGAT1 | |
| SCHEMBL12578322 | 0.88 | LIPG (0.61) | LIPGLPLESR1ESR2SNCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1991514-B1 | NOVEL ANTHRACENE DERIVATIVE AND ORGANIC ELECTRONIC DEVICE USING THE SAME | LG CHEMICAL LTD (KR) | 2017-12-20 | — | — | EP | disclosed |
| US-8222634-B2 | Anthracene derivatives and organic electronic device using the same | LG CHEM, LTD. (KR) | 2012-07-17 | — | — | US | disclosed |
| US-8222634-B2 | Anthracene derivatives and organic electronic device using the same | LG CHEM, LTD. (KR) | 2012-07-17 | — | — | US | disclosed |
| US-7965032-B2 | Anthracene derivative and organic electronic device using the same | LG CHEM, LTD. (KR) | 2011-06-21 | — | — | US | disclosed |
| US-7965032-B2 | Anthracene derivative and organic electronic device using the same | LG CHEM, LTD. (KR) | 2011-06-21 | — | — | US | disclosed |
| US-20110024725-A1 | ANTHRACENE DERIVATIVES AND ORGANIC ELECTRONIC DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2011-02-03 | — | — | US | disclosed |
| US-20110024725-A1 | ANTHRACENE DERIVATIVES AND ORGANIC ELECTRONIC DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2011-02-03 | — | — | US | disclosed |
| US-20070205412-A1 | Novel anthracene derivative and organic electronic device using the same | LG CHEM, LTD. (KR) | 2007-09-06 | — | — | US | disclosed |
| US-20070205412-A1 | Novel anthracene derivative and organic electronic device using the same | LG CHEM, LTD. (KR) | 2007-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110024725-A1 | ANTHRACENE DERIVATIVES AND ORGANIC ELECTRONIC DEVICE USING THE SAME | VDAC2, VDAC3, ANXA1 | LIPG 3587/4885LPL 4638/4885ESR1 23/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.